(Q38104321)

28 August 2017

The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease (English)

1 reference

28 August 2017

1 reference

Nicholas W Morrell

2

0 references

author name string

Paul D Upton

series ordinal

1

1 reference

28 August 2017

3 May 2013

1 reference

28 August 2017

Experimental Physiology

1 reference

28 August 2017

98

1 reference

28 August 2017

1262-1266

1 reference

28 August 2017

8

1 reference

Bmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertension

28 August 2017

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

The pathogenesis of idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Inflammation in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

ID family protein expression and regulation in hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by mo

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2012.069104

10.1113/EXPPHYSIOL.2012.069104

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23645549